Introduction
Pharmaceutical interviews evaluate much more than textbook knowledge. Interviewers commonly assess a candidate’s understanding of drug development, formulation, manufacturing, quality, regulatory requirements, pharmacology, pharmacovigilance, clinical research, and practical problem-solving. They also look for clarity of communication, scientific reasoning, awareness of Good Manufacturing Practices (GMP), and the ability to apply theoretical knowledge to real pharmaceutical situations.
The following 50 questions cover important areas frequently encountered in B.Pharm, M.Pharm, Pharm.D and pharmaceutical-industry interviews.
The answers are intentionally concise enough to remember while providing the technical depth expected from a professional candidate.
50 Pharma Interview Questions with Professional Answers
1. What is the difference between a pharmaceutical drug and an API?
Answer:
An API (Active Pharmaceutical Ingredient) is the pharmacologically active substance responsible for producing the intended therapeutic effect. A pharmaceutical drug product contains the API along with excipients and is manufactured into a suitable dosage form. For example, paracetamol is the API, while a paracetamol tablet is the finished pharmaceutical product. The finished product must meet defined quality, safety and performance specifications.
2. What are excipients, and why are they important?
Answer:
Excipients are inactive ingredients incorporated into pharmaceutical formulations for specific functional purposes. They can improve stability, manufacturability, appearance, dissolution, taste, preservation or drug release. Examples include binders, disintegrants, lubricants, preservatives and coating materials. Although generally pharmacologically inactive at their intended use level, excipients can significantly influence product performance.
3. What is bioavailability?
Answer:
Bioavailability refers to the rate and extent to which the active drug or active moiety becomes available in systemic circulation. For an intravenously administered drug, bioavailability is considered 100% because it directly enters systemic circulation. Oral bioavailability can be affected by dissolution, absorption, gastrointestinal conditions and first-pass metabolism. It is an important parameter in dosage-form and pharmacokinetic evaluation.
4. What is bioequivalence?
Answer:
Bioequivalence generally means that two pharmaceutical products do not show a significant difference in the rate and extent of drug exposure when administered under appropriate study conditions. It is particularly important when comparing a generic product with a reference product. Pharmacokinetic parameters such as AUC and Cmax are commonly evaluated. Regulatory agencies define specific statistical and study requirements for demonstrating bioequivalence.
5. What is dissolution testing?
Answer:
Dissolution testing measures the rate and extent at which an active pharmaceutical ingredient is released from a dosage form into a specified dissolution medium. It is particularly important for oral solid dosage forms such as tablets and capsules. The test helps evaluate batch-to-batch consistency and can provide information related to drug-release performance. Dissolution specifications are established according to the applicable product and regulatory requirements.
6. What is the difference between disintegration and dissolution?
Answer:
Disintegration is the process by which a tablet or capsule breaks down into smaller particles after administration. Dissolution is the subsequent process in which the drug substance goes into solution in the surrounding medium. Disintegration does not necessarily guarantee rapid or complete dissolution. Both properties can influence the performance of an immediate-release solid dosage form.


